Anshul Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anshul Sharma has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Hae-Jeung Lee
Department of Food and Nutrition, College of BioNano Technology, Gachon University, Seongnam 13120, Gyeonggi-do, Republic of Korea
7 shared publications Priyanka Sharma
College of Bionanotechnology, Department of Food and Nutrition, Gachon University, Seongnam-si, 13120, Gyeonggi-do, Republic of Korea
2 shared publicationsEun-Jung Park
College of Bionanotechnology, Department of Food and Nutrition, Gachon University, Seongnam-si, 13120, Gyeonggi-do, Republic of Korea; Institute for Aging and Clinical Nutrition Research, Gachon University, Seongnam-si, 13120, Gyeonggi-do, Republic of Korea
1 shared publication- Hana Baek
Department of Food Science and Biotechnology, College of BioNano Technology, Gachon University, Seongnam-si, Republic of Korea
1 shared publication - Jin-Young Han
Institute for Aging and Clinical Nutrition Research, Gachon University, Seongnam-Si, Korea
1 shared publication - Junho Yu
Department of Food Science and Biotechnology, College of BioNano Technology, Gachon University, Seongnam-si, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 30 January 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 182
Aster koraiensis Nakai: Insights into Its Phytoconstituents and Pharmacological Properties
Background/Objectives:Aster (A.) koraiensis (Nakai) Kitamura (synonym Gymnaster koraiensis), commonly referred to as Korean starwort, belongs to the composite (Asteraceae) family. This endemic perennial species is cultivated for its long-lasting ornamental flowers and for its young leaves and stems, which serve as a nutritious food source. It grows abundantly across the southern and central regions of the Korean Peninsula, including Jeju Island. The presence of diverse secondary metabolites such as phenolic compounds, polyacetylenes, benzofurans, flavonoids, triperpenoidal saponins, and sesquiterpenoids contributes to its importance in both traditional medicine and modern pharmacology. To date, no comprehensive review has been conducted to summarize its phytoconstituents and pharmacological potential. Methods: A non-systematic electronic search of English-language articles using A. koraiensis and its synonyms as keywords was conducted to assess its bioactive constituents and health-promoting potential. Results: This review seeks to compile and discuss the health-promoting activities of A. koraiensis, including its antioxidant, anti-inflammatory, anti-diabetic, anti-tumor, antithrombotic, anticoagulant, anti-angiogenic, antinociceptive, anti-metabolic syndrome, antiviral, hepatoprotective, and cognitive function-enhancing properties, based on evidence from cell and animal studies. To date, more than 75 phytoconstituents have been purified and characterized from this plant. Conclusions: The extensive pharmacological activities of A. koraiensis highlight its medicinal importance. Future studies should concentrate on the separation, identification, and quantification of its bioactive metabolites, alongside an in-depth investigation of its potential health-enhancing properties.
- 30 January 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 182
Open AccessAster koraiensis Nakai: Insights into Its Phytoconstituents and Pharmacological Properties
Background/Objectives:Aster (A.) koraiensis (Nakai) Kitamura (synonym Gymnaster koraiensis), commonly referred to as Korean starwort, belongs to the composite (Asteraceae) family. This endemic perennial species is cultivated for its long-lasting ornamental flowers and for its young leaves and stems, which serve as a nutritious food source. It grows abundantly across the southern and central regions of the Korean Peninsula, including Jeju Island. The presence of diverse secondary metabolites such as phenolic compounds, polyacetylenes, benzofurans, flavonoids, triperpenoidal saponins, and sesquiterpenoids contributes to its importance in both traditional medicine and modern pharmacology. To date, no comprehensive review has been conducted to summarize its phytoconstituents and pharmacological potential. Methods: A non-systematic electronic search of English-language articles using A. koraiensis and its synonyms as keywords was conducted to assess its bioactive constituents and health-promoting potential. Results: This review seeks to compile and discuss the health-promoting activities of A. koraiensis, including its antioxidant, anti-inflammatory, anti-diabetic, anti-tumor, antithrombotic, anticoagulant, anti-angiogenic, antinociceptive, anti-metabolic syndrome, antiviral, hepatoprotective, and cognitive function-enhancing properties, based on evidence from cell and animal studies. To date, more than 75 phytoconstituents have been purified and characterized from this plant. Conclusions: The extensive pharmacological activities of A. koraiensis highlight its medicinal importance. Future studies should concentrate on the separation, identification, and quantification of its bioactive metabolites, alongside an in-depth investigation of its potential health-enhancing properties.
- Open Access
- 23 October 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (11) , 415
Therapeutic Potential of Neopyropia yezoensis: An Updated Review
Neopyropia (N.) yezoensis is a widely cultivated red alga in East Asia and valued worldwide for its rich bioactive constituents recognized for their health benefits, including polsaccharides, porphyrans, pigments, phenolic compounds, phycobiliproteins, polyunsaturated fatty acids, myosporin-like amino acids, and both synthetic and recombinant peptides. This review summarizes the current knowledge regarding the therapeutic potential of N. yezoensis extracts and their bioactive compounds. Based on in vitro, ex vitro, and in vivo experimental data (including those on Drosophila melanogaster larvae), this review comprehensively discusses its antioxidant, anti-inflammatory, neuroprotective, anti-atopic dermatitis, anti-colitis, anticancer, anti-aging, anti-atrophy, metabolic health-promoting effects, improving renal health, proliferating, anti-osteoarthritic, anti-allergic, antibacterial, and antivirus activities. The prebiotic effect of N. yezoensis porphyran through modulation of the gut microbiota was also investigated. Studies have indicated that protein hydrolysates and peptides derived from N. yezoensis with low molecular weights and aromatic and/or hydrophobic amino acids contribute significantly to these diverse bioactivities. Although N. yezoensis has shown promising bioactivity in preclinical models, validated clinical data in humans are currently lacking. Future research should prioritize the design and implementation of well-controlled human clinical trials to fully explore their therapeutic potential.
- 23 October 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (11) , 415
Open AccessTherapeutic Potential of Neopyropia yezoensis: An Updated Review
Neopyropia (N.) yezoensis is a widely cultivated red alga in East Asia and valued worldwide for its rich bioactive constituents recognized for their health benefits, including polsaccharides, porphyrans, pigments, phenolic compounds, phycobiliproteins, polyunsaturated fatty acids, myosporin-like amino acids, and both synthetic and recombinant peptides. This review summarizes the current knowledge regarding the therapeutic potential of N. yezoensis extracts and their bioactive compounds. Based on in vitro, ex vitro, and in vivo experimental data (including those on Drosophila melanogaster larvae), this review comprehensively discusses its antioxidant, anti-inflammatory, neuroprotective, anti-atopic dermatitis, anti-colitis, anticancer, anti-aging, anti-atrophy, metabolic health-promoting effects, improving renal health, proliferating, anti-osteoarthritic, anti-allergic, antibacterial, and antivirus activities. The prebiotic effect of N. yezoensis porphyran through modulation of the gut microbiota was also investigated. Studies have indicated that protein hydrolysates and peptides derived from N. yezoensis with low molecular weights and aromatic and/or hydrophobic amino acids contribute significantly to these diverse bioactivities. Although N. yezoensis has shown promising bioactivity in preclinical models, validated clinical data in humans are currently lacking. Future research should prioritize the design and implementation of well-controlled human clinical trials to fully explore their therapeutic potential.
- 11 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 328 (Pt 2) , 147490
Mechanistic insights into the microbicidal activity of nanoparticles derived from high molecular weight fucoidan fraction extracted from Korean Undaria pinnatifida
- 11 September 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 328 (Pt 2) , 147490
Mechanistic insights into the microbicidal activity of nanoparticles derived from high molecular weight fucoidan fraction extracted from Korean Undaria pinnatifida
- Open Access
- 14 November 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (11) , 1389
A Review on the Protecting Effects and Molecular Mechanisms of Berries Against a Silent Public Health Concern: Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) poses a silent threat to human health, with prevalence rising at an alarming rate. The treatment and prevention of NAFLD depend on novel approaches as no effective treatment options are currently available. Berries are unique sources of phenolic compounds that have proven roles in disease prevention and health promotion. However, a comprehensive review of the effects of different berries on NAFLD and related pathologies is lacking. Thus, the present review aims to summarize the effects of berry extracts, plant parts, and bioactive compounds from twenty-one different berries on NAFLD. The molecular mechanisms involved include the regulation of lipid homeostasis, modulation of oxidative stress and inflammation markers, and activation of different signaling pathways in different in vitro and in vivo NAFLD models. Furthermore, their modulatory effects on the gut microbiota have also been highlighted. Clinical intervention research on the benefits of berries in NAFLD is limited; nonetheless, this paper discusses clinical studies demonstrating the effects of different berries in people with NAFLD. Future research should focus on long-term clinical studies to compare the therapeutic potentials of different berries against NAFLD.
- 14 November 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (11) , 1389
Open AccessA Review on the Protecting Effects and Molecular Mechanisms of Berries Against a Silent Public Health Concern: Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) poses a silent threat to human health, with prevalence rising at an alarming rate. The treatment and prevention of NAFLD depend on novel approaches as no effective treatment options are currently available. Berries are unique sources of phenolic compounds that have proven roles in disease prevention and health promotion. However, a comprehensive review of the effects of different berries on NAFLD and related pathologies is lacking. Thus, the present review aims to summarize the effects of berry extracts, plant parts, and bioactive compounds from twenty-one different berries on NAFLD. The molecular mechanisms involved include the regulation of lipid homeostasis, modulation of oxidative stress and inflammation markers, and activation of different signaling pathways in different in vitro and in vivo NAFLD models. Furthermore, their modulatory effects on the gut microbiota have also been highlighted. Clinical intervention research on the benefits of berries in NAFLD is limited; nonetheless, this paper discusses clinical studies demonstrating the effects of different berries in people with NAFLD. Future research should focus on long-term clinical studies to compare the therapeutic potentials of different berries against NAFLD.
- 30 September 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281, 135536
Antioxidant potential of exopolysaccharides from lactic acid bacteria: A comprehensive review
- 30 September 2024
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 281, 135536
Antioxidant potential of exopolysaccharides from lactic acid bacteria: A comprehensive review
- Open Access
- 19 December 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (12) , 2496
Stevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in db/db Mice Hepatocytes
Lipophagy, a type of autophagy that breaks down lipid droplets, is essential in the regulation of intracellular lipid accumulation and intracellular free fatty acid levels in numerous organisms and metabolic conditions. We investigated the effects of Stevia rebaudiana Bertoni (S), a low-calorie sweetener, and stevioside (SS) on hepatic steatosis and autophagy in hepatocytes, as well as in db/db mice. S and SS reduced the body and liver weight and levels of serum triglyceride, total cholesterol, and hepatic lipogenic proteins. In addition, S and SS increased the levels of fatty acid oxidase, peroxisome proliferator-activated receptor alpha (PPARα), and microtubule-associated protein light chain 3 B but decreased that of sequestosome 1 (p62) in the liver of db/db mice. Additionally, Beclin 1, lysosomal associated membrane protein 1, and phosphorylated adenosine monophosphate-activated protein kinase protein expression was augmented following S and SS treatment of db/db mice. Furthermore, the knockdown of PPARα blocked lipophagy in response to SS treatment in HepG2 cells. These outcomes indicate that PPARα-dependent lipophagy is involved in hepatic steatosis in the db/db mouse model and that SS, a PPARα agonist, represents a new therapeutic option for managing associated diseases.
- 19 December 2022
- Published by MDPI AG in Antioxidants
- Vol. 11 (12) , 2496
Open AccessStevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in db/db Mice Hepatocytes
Lipophagy, a type of autophagy that breaks down lipid droplets, is essential in the regulation of intracellular lipid accumulation and intracellular free fatty acid levels in numerous organisms and metabolic conditions. We investigated the effects of Stevia rebaudiana Bertoni (S), a low-calorie sweetener, and stevioside (SS) on hepatic steatosis and autophagy in hepatocytes, as well as in db/db mice. S and SS reduced the body and liver weight and levels of serum triglyceride, total cholesterol, and hepatic lipogenic proteins. In addition, S and SS increased the levels of fatty acid oxidase, peroxisome proliferator-activated receptor alpha (PPARα), and microtubule-associated protein light chain 3 B but decreased that of sequestosome 1 (p62) in the liver of db/db mice. Additionally, Beclin 1, lysosomal associated membrane protein 1, and phosphorylated adenosine monophosphate-activated protein kinase protein expression was augmented following S and SS treatment of db/db mice. Furthermore, the knockdown of PPARα blocked lipophagy in response to SS treatment in HepG2 cells. These outcomes indicate that PPARα-dependent lipophagy is involved in hepatic steatosis in the db/db mouse model and that SS, a PPARα agonist, represents a new therapeutic option for managing associated diseases.
- Open Access
- 5 December 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (12) , 1236
A Review of Recent Studies on the Antioxidant Activities of a Third-Millennium Food: Amaranthus spp.
Amaranth (Amaranthus spp.) plant commonly refers to the sustainable food crop for the 21st century. The crop has witnessed significant attention in recent years due to its high nutritional value and agronomic advantages. It is a relatively well-balanced cosmopolitan food that is a protector against chronic diseases. Usually, the antioxidant activities of amaranth are held responsible for its defensive behavior. Antioxidant activity of plants, generally, is attributed to their phytochemical compounds. The current interest, however, lies in hydrolysates and bioactive peptides because of their numerous biological functions, including antioxidant effect. While the importance of bioactive peptides has been progressively recognized, an integrated review of recent studies on the antioxidant ability of amaranth species, especially their hydrolysates and peptides has not been generated. Hence, in this review, we summarize studies focused on the antioxidant capacity of amaranth renewal over the period 2015–2020. It starts with a background and overall image of the amaranth-related published reviews. The current research focusing on in vitro, in vivo, and chemical assays-based antioxidant activity of different amaranth species are addressed. Finally, the last segment includes the latest studies concerning free radical scavenging activity and metal chelation capacity of amaranth protein hydrolysates and bioactive peptides.
- 5 December 2020
- Published by MDPI AG in Antioxidants
- Vol. 9 (12) , 1236
Open AccessA Review of Recent Studies on the Antioxidant Activities of a Third-Millennium Food: Amaranthus spp.
Amaranth (Amaranthus spp.) plant commonly refers to the sustainable food crop for the 21st century. The crop has witnessed significant attention in recent years due to its high nutritional value and agronomic advantages. It is a relatively well-balanced cosmopolitan food that is a protector against chronic diseases. Usually, the antioxidant activities of amaranth are held responsible for its defensive behavior. Antioxidant activity of plants, generally, is attributed to their phytochemical compounds. The current interest, however, lies in hydrolysates and bioactive peptides because of their numerous biological functions, including antioxidant effect. While the importance of bioactive peptides has been progressively recognized, an integrated review of recent studies on the antioxidant ability of amaranth species, especially their hydrolysates and peptides has not been generated. Hence, in this review, we summarize studies focused on the antioxidant capacity of amaranth renewal over the period 2015–2020. It starts with a background and overall image of the amaranth-related published reviews. The current research focusing on in vitro, in vivo, and chemical assays-based antioxidant activity of different amaranth species are addressed. Finally, the last segment includes the latest studies concerning free radical scavenging activity and metal chelation capacity of amaranth protein hydrolysates and bioactive peptides.